| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecular Medicine |
B and Related Proinflammatory Genes in Vascular Smooth Muscle Cells
From the Vascular and Renal Research Laboratory (V.E., M.R., E.S.-L., J.R.-V., O.L., J.E., M.R.-O.), Fundación Jiménez Diaz, Universidad Autónoma Madrid, Spain; and the Department of Molecular and Biochemical Pharmacology (H.D., P.V.), Institute for Molecular Biology and Biotechnology, Vrije Univerisiteit Brussel, Belgium.
Correspondence to Marta Ruiz-Ortega, PhD, Vascular and Renal Research Laboratory, Fundación Jiménez Díaz, Universidad Autónoma de Madrid Avda, Reyes Católicos, 2, 28040 Madrid, Spain. E-mail mruizo{at}fjd.es
Inflammation is a key event in the development of atherosclerosis. Nuclear factor-
B (NF-
B) is important in the inflammatory response regulation. The effector peptide of the renin angiotensin system Angiotensin II (Ang II) activates NF-
B and upregulates some related proinflammatory genes. Our aim was to investigate whether other angiotensin-related peptides, as the N-terminal degradation peptide Ang IV, could regulate proinflammatory factors (activation of NF-
B and related genes) in cultured vascular smooth muscle cells (VSMCs). In these cells, Ang IV increased NF-
B DNA binding activity, caused nuclear translocation of p50/p65 subunits, cytosolic I
B degradation and induced NF-
Bdependent gene transcription. Ang II activates NF-
B via AT1 and AT2 receptors, but AT1 or AT2 antagonists did not inhibit NF-
B activation caused by Ang IV. In VSMC from AT1a receptor knockout mice, Ang IV also activated NF-
B pathway. In those cells, the AT4 antagonist divalinal diminished dose-dependently Ang IVinduced NF-
B activation and prevented I
B degradation, but had no effect on the Ang II response, indicating that Ang IV activates the NF-
B pathway via AT4 receptors. Ang IV also increased the expression of proinflammatory factors under NF-
B control, such as MCP-1, IL-6, TNF-
, ICAM-1, and PAI-1, which were blocked by the AT4 antagonist. Our results reveal that Ang IV, via AT4 receptors, activates NF-
B pathway and increases proinflammatory genes. These data indicate that Ang IV possesses proinflammatory properties, suggesting that this Ang degradation peptide could participate in the pathogenesis of cardiovascular diseases.
Key Words: angiotensin IV signal transduction nuclear factor
B vascular smooth muscle cell insulin regulated aminopeptidase
This article has been cited by other articles:
![]() |
Y. Numaguchi, M. Ishii, R. Kubota, Y. Morita, K. Yamamoto, T. Matsushita, K. Okumura, and T. Murohara Ablation of Angiotensin IV Receptor Attenuates Hypofibrinolysis via PAI-1 Downregulation and Reduces Occlusive Arterial Thrombosis Arterioscler Thromb Vasc Biol, December 1, 2009; 29(12): 2102 - 2108. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Sanchez-Lopez, S. Rayego, R. Rodrigues-Diez, J. S. Rodriguez, R. Rodrigues-Diez, J. Rodriguez-Vita, G. Carvajal, L. S. Aroeira, R. Selgas, S. A. Mezzano, et al. CTGF Promotes Inflammatory Cell Infiltration of the Renal Interstitium by Activating NF-{kappa}B J. Am. Soc. Nephrol., July 1, 2009; 20(7): 1513 - 1526. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Y. Lee, S. D. Kim, J. W. Shim, S. Y. Lee, H. Lee, K.-H. Cho, J. Yun, and Y.-S. Bae Serum Amyloid A Induces CCL2 Production via Formyl Peptide Receptor-Like 1-Mediated Signaling in Human Monocytes J. Immunol., September 15, 2008; 181(6): 4332 - 4339. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vinh, R. E. Widdop, G. R. Drummond, and T. A. Gaspari Chronic angiotensin IV treatment reverses endothelial dysfunction in ApoE-deficient mice Cardiovasc Res, January 1, 2008; 77(1): 178 - 187. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kotlo, S. Shukla, U. Tawar, R. A. Skidgel, and R. S. Danziger Aminopeptidase N reduces basolateral Na+-K+-ATPase in proximal tubule cells Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1047 - F1053. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Liu, Y. Yang, C. Gu, Y. Yue, K. K. Wu, J. Wu, and Y. Zhu Spike protein of SARS-CoV stimulates cyclooxygenase-2 expression via both calcium-dependent and calcium-independent protein kinase C pathways FASEB J, May 1, 2007; 21(7): 1586 - 1596. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tedgui and Z. Mallat Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways Physiol Rev, April 1, 2006; 86(2): 515 - 581. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Wolf 'As time goes by': angiotensin II-mediated transactivation of the EGF receptor comes of age Nephrol. Dial. Transplant., October 1, 2005; 20(10): 2050 - 2053. [Full Text] [PDF] |
||||
![]() |
I. Haulica, W. Bild, and D. N Serban Review: Angiotensin Peptides and their Pleiotropic Actions Journal of Renin-Angiotensin-Aldosterone System, September 1, 2005; 6(3): 121 - 131. [Abstract] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |